bisbenzimidazole has been researched along with Cerebral Infarction in 1 studies
Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.
Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, J | 1 |
| Kuroda, S | 1 |
| Shichinohe, H | 1 |
| Ikeda, J | 1 |
| Seki, T | 1 |
| Hida, K | 1 |
| Tada, M | 1 |
| Sawada, K | 1 |
| Iwasaki, Y | 1 |
1 other study available for bisbenzimidazole and Cerebral Infarction
| Article | Year |
|---|---|
Migration and differentiation of nuclear fluorescence-labeled bone marrow stromal cells after transplantation into cerebral infarct and spinal cord injury in mice.
Topics: Animals; Bisbenzimidazole; Bone Marrow Cells; Bone Marrow Transplantation; Cell Differentiation; Cel | 2003 |